Vireo growth sees $25k stock purchase by Chicago Atlantic Credit

In a recent transaction, Chicago Atlantic Credit Opportunities, LLC, a significant shareholder in Vireo Growth Inc. (NASDAQ:VREO), acquired 60,000 Subordinate Voting Shares of the company. The shares were purchased at a weighted average price of $0.4193 per share, totaling approximately $25,158. According to InvestingPro data, this purchase comes as the stock has fallen over 24% in the past week, with the current market capitalization standing at $139 million. The transaction occurred on April 4, 2025, and was disclosed in a Form 4 filing with the Securities and Exchange Commission.

This acquisition adds to Chicago Atlantic's existing holdings, bringing their total direct ownership to 11,206,278 shares. The firm has been involved in previous transactions with Vireo Growth, as noted in their filings.

The purchase price for the shares ranged between $0.4018 and $0.44, according to the filing. The transaction highlights Chicago Atlantic's continued interest in Vireo Growth, a company classified under pharmaceutical preparations. Based on InvestingPro's Fair Value analysis, the stock appears undervalued at current levels. Unlock 6 additional ProTips and comprehensive financial analysis with an InvestingPro subscription.

In other recent news, Vireo Growth Inc. reported a 15.4% increase in full-year revenue, reaching $99.4 million, with fourth-quarter revenue up 3.5% to $25 million. Despite these gains, the company experienced a net loss of $15.7 million in the fourth quarter, primarily due to one-time transaction expenses. Vireo Growth is focusing on strategic initiatives, including a new cultivation facility and expansion into adult-use sales, which are expected to contribute to a transformative year ahead. The company ended the year with a strong cash position of $91.6 million, following an $81 million private placement. Vireo Growth anticipates significant contributions from its New York facility in 2025, with projections indicating continued revenue growth. The company is also planning mergers expected to close in 2025, pending regulatory and shareholder approvals. Analysts have expressed interest in the timeline for Vireo's new Minnesota facility, which is expected to be completed within 2025. Additionally, Vireo Growth is planning to divest a portion of its New York assets while focusing on producing high-end cannabis flower.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.